Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells
Primary tumors are metabolically dependent on the Warburg pathway for fast energy and carbon sources, and several oncogenic activations feed into it. The first line of cancer therapy with multiple pathway blockers can inhibit the oncogenic activations, but in turn, cancer cells reprogram themselves, and dependency upon the Warburg pathway shifts to other metabolic pathways. Moreover, the theory of CSC’s self-renewal is now a popular area of study, which might be a factor that controls tumor recurrence. The evolved drug-resistant tumors are more aggressive and do metastasize to distant sites in the human body and form secondary tumors. CSC: cancer stem cells, “↑” indicates upregulation and “?” indicates the probable pathway activation (This figure was drawn using the Bio Render app).